Bitter Orange (p-Synephrine): The Definitive Guide

What is Bitter Orange (p-Synephrine)?

Bitter-orange extracts vary in p-synephrine and often include caffeine. Current pooled evidence does not establish weight loss and suggests blood-pressure and heart-rate effects. NIH ODS describes weight-loss evidence as inconclusive and safety concerns as greatest in multi-stimulant products. There is no RDA, AI, UL or established weight-loss dose. [1]

Typical Bitter Orange (p-Synephrine) Protocols

These rows reproduce sources. Do not average them into one universal regimen.

Which forms and label details matter?

Record Citrus aurantium plant part, extract ratio, p-synephrine milligrams, not just extract mass, and every caffeine or stimulant source. p-Synephrine, m-synephrine/phenylephrine and ephedrine are not interchangeable.

How should it be stored?

Follow the label, close the container and protect it from heat, light and moisture.

What is it commonly used for?

It is marketed for thermogenesis, appetite, weight and pre-workout energy. Acute energy-expenditure changes are surrogate outcomes and have not translated into established weight loss.

What does human research show?

NIH ODS concludes that bitter-orange weight evidence is contradictory and weak, with small trials frequently confounded by caffeine, diet, exercise and other ingredients. [1] Bui’s 15-person crossover trial gave 900 mg extract standardized to 6% p-synephrine once; systolic pressure, diastolic pressure and heart rate were higher than placebo for parts of the six-hour observation. [2] A separate 16-person crossover study using 49 mg/day for 15 days found no significant hemodynamic change, illustrating the small and inconsistent safety record. [3] A 2022 meta-analysis of 18 placebo-controlled reports found no significant long-duration weight or body-composition benefit, while prolonged use increased pooled systolic and diastolic pressure. [4]

How might it act?

p-Synephrine can interact with adrenergic signaling and may alter energy expenditure. A transient metabolic-rate change does not establish fat loss and stimulant combinations change both exposure and risk.

How does it compare with related products?

What are the risks and interactions?

Avoid self-use with cardiovascular disease, uncontrolled hypertension, arrhythmia, pregnancy or breastfeeding. Review stimulants, caffeine, decongestants, ADHD medicines, thyroid treatment, MAO inhibitors and other interacting drugs. Stop and seek care for chest pain, fainting, severe headache or persistent palpitations.

Which medicines require review?

Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.

Common questions about Bitter Orange (p-Synephrine)

Is bitter orange the same as ephedra?

No, but both can appear in stimulant-marketed contexts and should not be treated as interchangeable.

Does it cause weight loss?

Current controlled evidence does not establish a meaningful weight effect.

Why record caffeine?

It can independently affect heart rate, blood pressure, sleep and energy expenditure.

Is 54 mg a daily recommendation?

No. It was one single-dose safety exposure.

Can athletes assume it is safe?

No. Product composition and anti-doping contamination risk require sport-specific review.

What should I track?

Extract, p-synephrine mg, all stimulants, each administration, blood pressure, pulse, sleep, symptoms and review date.

Glossary

Terms for reading the evidence.

Active amount

The declared amount of the ingredient of interest, distinct from total blend mass.

Daily total

The sum across administrations; it does not reveal amount each time.

Randomized trial

A study assigning an intervention and comparator by chance.

Surrogate outcome

A measure such as energy expenditure that is not weight loss itself.

Co-ingredient

Another active substance that can alter benefit or risk.

Clinical importance

Whether a measured difference is large enough to matter in practice.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources